SEP 10, 2026 · PHASE 1/2 TRIAL
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 1/2 trial registration with no posted results; it describes a planned early-phase study of a novel combination in a difficult-to-treat cancer.
Reported
Estimated enrollment45
Study phasePhase 1/2
Primary outcome measureProgression-free survival, from start of tr…